21st Annual Clinical Breakthrough and Challenges in Hematologic Malignancies Conference

21st Annual Clinical Breakthrough and Challenges in Hematologic Malignancies Conference is organized by Moffitt Cancer Center and will be held on Jan 24, 2026 at The Don CeSar, Saint Pete Beach, Florida, United States of America.

Description:
The 21st Annual Clinical Breakthroughs and Challenges in Hematologic Malignancies conference presents the most recent diagnostic and therapeutic advances and treatment options in hematologic malignancies to practicing hematologists, oncologists, pharmacists, advanced practice professionals and oncology nurses. This one-day conference will cover lymphoid malignancies, myeloid malignancies, multiple myeloma and current hot topics in blood cancers. Interactive and interactive debates. Ample time will be available for networking.

Learning Objectives:

• Understand the management of mantle cell lymphoma. 
• Recognize unique issues facing adolescents and young adults undergoing treatment of lymphoma. 
• Discuss the role of T cell therapy in low grade lymphomas. 
• Describe the frequency of clonal hematopoiesis mutations in older individuals and the associated risk with future hematologic malignancies. 
• Discuss the role of new agents such as Luspatercept and Imetelstat in MDS. 
• Recognize the technical and clinical limitations of MRD testing in Myeloid Malignancies. 
• Describe the management of myeloma patients at post-CART relapse. 
• Understand the definition of high-risk myeloma and the differences in management of high-risk vs. standard risk disease. 
• Discuss benefits, risks, and indication of cilta-cel as second line.